SC
JAZZ icon

Syon Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History

Syon Capital’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$363K Buy
1,507
+104
+7% +$22.8K 0.02% 739
2026
Q1 		$265K Sell
1,403
-305
-18% -$53.3K 0.01% 780
2025
Q4 		$290K Buy
+1,708
New +$262K 0.01% 755

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Syon Capital's JAZZ Position: Q2 2026 in Review

Syon Capital increased its Jazz Pharmaceuticals (JAZZ) stake by 7.4% in Q2 2026, buying an estimated $22.8K and bringing the position to 1,507 shares worth $363K. The position accounts for 0.02% of the portfolio, ranked #739.

Syon Capital first reported a position in JAZZ in Q4 2025 and has held it in 3 quarters since. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Syon Capital held 1,507 shares of Jazz Pharmaceuticals worth $363K as of Q2 2026.
  • Syon Capital bought 104 Jazz Pharmaceuticals shares in Q2 2026, an estimated $22.8K.
  • Jazz Pharmaceuticals made up 0.02% of Syon Capital's portfolio in Q2 2026, its #739 holding.
  • Syon Capital first reported a position in Jazz Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.